Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/91666
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMikocka-Walus, A.A.-
dc.contributor.authorAndrews, J.-
dc.contributor.authorVon Kaenel, R.-
dc.contributor.authorMoser, G.-
dc.date.issued2012-
dc.identifier.citationJournal of Gastroenterology and Hepatology, 2012, vol.27, iss.Suppl. 4, pp.111-111-
dc.identifier.issn0815-9319-
dc.identifier.issn1440-1746-
dc.identifier.urihttp://hdl.handle.net/2440/91666-
dc.description.statementofresponsibilityAntonina A Mikocka-Walus, Jane Andrews, Roland Von Känel, Gabriele Moser-
dc.language.isoen-
dc.publisherWiley-
dc.rights© 2012 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd-
dc.source.urihttp://dx.doi.org/10.1111/j.1440-1746.2011.07251_6.x-
dc.titleWhat are the implications of changing treatment delivery models for inflammatory bowel disease (IBD) sufferers?-
dc.typeConference item-
dc.contributor.conferenceAustralian Gastroenterology Week 2012 (16 Oct 2012 - 19 Oct 2012 : Adelaide, SA)-
dc.identifier.doi10.1111/j.1440-1746.2011.07251_6.x-
pubs.publication-statusPublished-
dc.identifier.orcidMikocka-Walus, A.A. [0000-0003-4864-3956]-
Appears in Collections:Aurora harvest 2
Psychology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.